Agios Pharma (AGIO) Reports Q2 Loss of $1.47/Share

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.47), versus ($0.85) reported last year. Revenue for the quarter came in at $6.98 million, versus $13.22 million reported last year.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
• Sun Communities names Ileana McAlary as general counsel and EVP